NCT04546451: COPE

Countervail Cognitive and Cerebral Decline in Mild Cognitive Impairment Patients Using Non-medical Interventions

Completed NA Last updated 1 June 2023

What this trial tests

NA trial testing Music practice in Mild Cognitive Impairment in 48 participants. Completed in 27 May 2023.

Timeline

1 January 2021

Primary endpoint
27 March 2023

27 May 2023

Quick facts

Lead sponsor	School of Health Sciences Geneva
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	48
Start date	1 January 2021
Primary completion	27 March 2023
Estimated completion	27 May 2023
Sites	2 locations across Switzerland

Drugs / interventions tested

• Music practice
• Psychomotor therapy

Conditions studied

• Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

School of Health Sciences Geneva

Who can join

Adults 60 to 80, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive decline represents a major threat among the deleterious effects of population aging. The investigators propose to conduct an RCT (randomized controlled trial) on the subpopulation of MCI patients, and examine whether intensive musical or psychomotor group interventions can improve their cognitive and sensorimotor functioning, as well as induce brain plasticity, compared to a passive healthy control group, matched for age, gender and education level. The 2 training regimens will take place twice a week over 6 months and will be provided by professionals in each field.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.